Rabix-VC is a freeze-dried lyophilized powder of purified, inactivated rabies virus vaccine produced on Vero cell. After reconstitution the vaccine is a clear, sterile solution. Each ml contains 1 immunizing dose (protective power is >2.5 IU) in vial for i.m injection.
Dosage & admin: lml for children and adults:
a)    Pre-exposure immunization: Primary-vaccination: According to the WHO recommendations 1 injection by the intramus¬cular route on days DO, D7, D21 or D28, followed by a booster dose 1 year later. Boosters: Thereafter, one injection every 5 years or when the titre is found to be less than 0.5 IU/ml.
b)    Post-exposure treatment:
Non-vaccinated individuals: Treatment consists of 5 injections. Intramuscular injections to be given on days DO, D3, D7, D14 and D28 subse¬quent to contact with an animal confirmed or suspected of being rabid. In case of severe (WHO category 3) wounds, immunoglobulin should be administered as soon as possible. Fully vaccinated individuals: If vaccine admini¬stered in less than 5 years of exposure (cell culture rabies vaccine): 2 injections on DO, D3.
If vaccine administered in more than 5 years •f exposure or incomplete vaccination: 5 injections on DO, D3, D7, D14 and D28 with administration of immunoglobulin if required. Post exposure vaccination must be administered on the basis of severity under medical supervision,
lml vial (single dose): 500.00 MRP